* The only company from pharmaceutical industry selected for inclusion in the Index * Also incl...
SHANGHAI, Oct. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research...
* TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integratio...
SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Resear...
WUXI, China, Sept. 17, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Res...
* End-to-end Green CRDMO solutions to enable global clients for broader positive impact * Span ...
* Committed to net-zero across the value chain by 2050 * Aligned with 1.5°C mitigation pathways,...
* Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operation...
* Building on its success in developing continuous production at pilot-scale with the WuXiUP™ pla...
* WuXia293Stable platform demonstrates high titer, human glycosylation and improved product quali...
* Earns CDP's highest rating for supply chain engagement on climate * Adds to other CDP recognit...
* Innovative modular design will accelerate construction and manufacturing timelines, enabling ra...
* Best ESG rating tier of negligible-risk with a top 1% global ranking score * Industry and Regi...
* The WuXiHigh™2.0 technology platform harnesses proprietary excipient blends and expertise to en...
* Contributing to United Nations Sustainable Development Goals * Enhancing transparency and effe...
* Firm commitment to tackling climate change in support of United Nations Sustainable Development...
- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,...
SHANGHAI, April 14, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Co...
* Revenue grew 9.6% YoY to RMB 18,675.4 million, with non-COVID revenue up 13.1% YoY * Adjusted...
* Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development ...